搜索结果11-20 的 26057 / Maximum

  1. 神经科- 临床试验- 妙佑医疗国际

    The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

  2. 神经科- 临床试验- 妙佑医疗国际

    The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

  3. 神经科- 临床试验- 妙佑医疗国际

    The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

  4. 神经科- 临床试验- 妙佑医疗国际

    The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

  5. 神经科- 临床试验- 妙佑医疗国际

    The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

  6. 血液科- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

  7. 神经科- 临床试验- 妙佑医疗国际

    The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

  8. 肺癌计划- 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

  9. 皮肤科- 临床试验- 妙佑医疗国际

    ... maximum dose that can be administered until adverse effects prevent further dose increases (i.e., the MTD or recommended phase 2 dose), and the dose ...

  10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...